The paper introduces Guided Deep List, a tool for automating the generation of epidemiological line lists from open source reports. The tool uses distributed vector representations and dependency parsing to extract tabular data on disease outbreaks. It was evaluated on MERS outbreak data in Saudi Arabia, demonstrating improved accuracy over baseline methods and enabling epidemiological inferences.
KAUST researchers developed CovMT, a COVID-19 mutation tracking system for authorities and scientists to detect variants. CovMT tracks mutation fingerprints using daily data from the GISAID database of over 1.5 million viral genomes. The system identifies mutation hot spots, enabling public health authorities to stay ahead of new variants. Why it matters: This system provides a tool for rapid variant detection and informed public health decision-making in the region and globally.
The KAUST Pathogen Genomics Laboratory (PGL), led by Professor Arnab Pain, is using DNA and RNA sequencing to study the SARS-CoV-2 virus. The lab is part of KAUST's Rapid Research Response Team (R3T), supporting Saudi healthcare stakeholders in combating COVID-19. Pain and his Ph.D. student Sharif Hala are partnering with the Saudi-CDC and Ministry of Health hospitals to sequence Saudi SARS-CoV-2 samples. Why it matters: This effort provides crucial data for understanding and monitoring the virus's spread and evolution within the Kingdom, informing public health strategies.
This study investigates the correlation between Google Trends data for COVID-19 symptoms and the actual number of COVID-19 cases in Saudi Arabia between March and October 2020. The researchers found that searches for "cough" and "sore throat" were most frequent, while "loss of smell", "loss of taste", and "diarrhea" showed the highest correlation with confirmed cases. The study concludes that Google searches can serve as a supplementary surveillance tool for monitoring the spread of COVID-19 in Saudi Arabia. Why it matters: The research demonstrates the potential of using readily available digital data to augment traditional surveillance methods for public health monitoring in the region.
Dr. Mikhail Burtsev of the London Institute presented research on GENA-LM, a suite of transformer-based DNA language models. The talk addressed the challenge of scaling transformers for genomic sequences, proposing recurrent memory augmentation to handle long input sequences efficiently. This approach improves language modeling performance and holds promise for memory-intensive applications in bioinformatics. Why it matters: This research can significantly advance AI's capabilities in genomics by enabling the processing of much larger DNA sequences, with potential breakthroughs in understanding and treating diseases.
KAUST researchers are analyzing the SARS-CoV-2 genome to identify potential targets for treatment and vaccine development. They are using the KAUST Metagenome Analysis Platform (KMAP) and the university's supercomputer to compare and analyze genomic data. The research focuses on identifying key genes for detection and treatment of COVID-19. Why it matters: This research contributes to the global effort to combat the pandemic and highlights KAUST's capabilities in genomic data analysis and computational bioscience.
KAUST is joining universities worldwide to expedite licensing for COVID-19 related technologies. KAUST researchers are focusing on developing rapid diagnostic platforms, genomic analyses, and tools to track the virus's spread, collaborating with Saudi healthcare stakeholders. By signing the AUTM COVID-19 Licensing Guidelines and adopting the COVID-19 Technology Development Framework, KAUST will offer royalty-free, time-limited, non-exclusive licenses during and after the pandemic. Why it matters: This initiative facilitates quicker development and broader access to essential technologies for combating COVID-19 in Saudi Arabia and the Middle East.